This aligns with major studies that provided important research and significant evidence on the association between APC promoter aberrant methylation and the risk of BLCA and affirmed the potential of methylated urine APC promoter as a reliable biomarker for bladder carcinogenesis [22]. The gene discussed is APC; the disease is bladder transitional cell carcinoma.